0
Login/Register

Library

Shape Image One
  1. Amniocentesis and Chorionic Villus Sampling (Green-top Guideline No. 8) 2021

  2. Antenatal corticosteroids to reduce neonatal morbidity and mortality (Green-top Guideline 74) 2022

  3. Antenatal Corticosteroids to Reduce Neonatal Morbidity (Green-top Guideline No. 7)
  4. Assisted Vaginal Birth (Green-top Guideline No. 26) 2020

  5. Diagnosis and Management of Ectopic Pregnancy (Green-top Guideline No. 21)
  6. Antepartum Haemorrhage (Green-top Guideline No. 63)
  7. Birth after Previous Caesarean Birth (Green-top Guideline No. 45)
  8. Blood Transfusions in Obstetrics (Green-top Guideline No. 47)
  9. Pregnancy and Breast Cancer (Green-top Guideline No. 12)
  10. Care after non-invasive pre-natal testing (Green-top Guideline) (1)
  11. Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24+0 Weeks of Gestation (Green-top Guideline No. 73) 2019

  12. Care of Women with Obesity in Pregnancy (Green-top Guideline No. 72) 2018

  13. Cervical cerclage (Green-top Guideline No. 75) 2022

  14. Cervical Cerclage (Green-top Guideline No. 60)
  15. Chickenpox in Pregnancy (Green-top Guideline No. 13)
  16. The Initial Management of Chronic Pelvic Pain (Green-top Guideline No. 41) Early Pregnancy Loss, Management (Green-top Guideline No. 25)
  17. Endometriosis, Investigation and Management (Green-top Guideline No. 24)
  18. Epilepsy in Pregnancy (Green-top Guideline No. 68)
  19. External Cephalic Version and Reducing the Incidence of Term Breech Presentation (Green-top Guideline No. 20a)
  20. Female Genital Mutilation and its Management (Green-top Guideline No. 53)
  21. Genital Herpes in Pregnancy, Management (Green-top Guideline No. 30)
  22. Gestational Trophoblastic Disease (Green-top Guideline No. 38) 2020

  23. Prevention of Early-onset Group B Streptococcal Disease (Green-top Guideline No. 36)
  24. HIV in Pregnancy, Management (Green-top Guideline No. 39)
  25. Hysteroscopy, Best Practice in Outpatient (Green-top Guideline No. 59)
  26. Management of Inherited Bleeding Disorders in Pregnancy (Green-top Guideline No. 71)
  27. Laparoscopic Injuries (Green-top Guideline No. 49)
  28. Late Intrauterine Fetal Death and Stillbirth (Green-top Guideline No. 55)
  29. The Diagnosis and Treatment of Malaria in Pregnancy (Green-top Guideline No. 54b)
  30. Malaria in Pregnancy, Prevention (Green-top Guideline No. 54A)
  31. Management of Bladder Pain Syndrome (Green-top Guideline No. 70)
  32. Management of Breech Presentation (Green-top Guideline No. 20b)
  33. Management of Endometrial Hyperplasia (Green-top Guideline No. 67)
  34. Maternal Collapse in Pregnancy and the Puerperium (Green-top Guideline No. 56)2019

  35. Management of Monochorionic Twin Pregnancy (Green-top Guideline No. 51)
  36. Intrahepatic cholestasis of pregnancy (Green-top Guideline No. 43) 2022

  37. Ovarian Cysts in Postmenopausal Women (Green-top Guideline No. 34)
  38. The Management of Ovarian Hyperstimulation Syndrome (Green-top Guideline No. 5)
  39. Ovarian Masses in Premenopausal Women, Management of Suspected (Green-top Guideline No. 62)
  40. Management of Suspected Ovarian Masses in Premenopausal Women (Green-top Guideline No. 62)
  41. Pelvic Inflammatory Disease (Green-top Guideline No. 32)
  42. Placenta Praevia, Placenta Praevia Accreta and Vasa Praevia: Diagnosis and Management (Green-top Guideline No. 27)
  43. Placenta Praevia and Placenta Accreta: Diagnosis and Management (Green-top Guideline 27a)2018

  44. Long-term Consequences of Polycystic Ovary Syndrome (Green-top Guideline No. 33)
  45. Post-Hysterectomy Vaginal Vault Prolapse (Green-top Guideline No. 46)
  46. Prevention and Management of Postpartum Haemorrhage (Green-top Guideline No. 52)
  47. Premenstrual Syndrome, Management (Green-top Guideline No. 48)
  48. Preterm Labour, Tocolytic Drugs (Green-top Guideline No. 1B)
  49. Preterm Prelabour Rupture of Membranes (Green-top Guideline No. 44)
  50. Recurrent Miscarriage (Green-top Guideline No. 17) 2023

  51. Reduced Fetal Movements (Green-top Guideline No. 57)
  52. The Use of Anti-D Immunoglobulin for Rhesus D Prophylaxis (Green-top Guideline No. 22)
  53. Bacterial Sepsis following Pregnancy (Green-top Guideline No. 64b)
  54. Sepsis in Pregnancy, Bacterial (Green-top Guideline No. 64a)
  55. Severe Pre-eclampsia/Eclampsia, Management (Green-top Guideline No. 10a)
  56. Shoulder Dystocia (Green-top Guideline No. 42)
  57. Sickle Cell Disease in Pregnancy, Management of (Green-top Guideline No. 61)
  58. Small-for-Gestational-Age Fetus, Investigation and Management (Green-top Guideline No. 31)
  59. Management of Beta Thalassaemia in Pregnancy (Green-top Guideline No. 66)
  60. The Management of Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69)
  61. The Management of Women with Red Cell Antibodies during Pregnancy (Green-top Guideline No. 65)
  62. Third- and Fourth-degree Perineal Tears, Management (Green-top Guideline No. 29)
  63. Reducing the Risk of Thrombosis and Embolism during Pregnancy and the Puerperium (Green-top Guideline No. 37a)
  64. Thrombosis and Embolism during Pregnancy and the Puerperium: Acute Management (Green-top Guideline No. 37b)
  65. Umbilical Cord Prolapse (Green-top Guideline No. 50)
  66. Urodynamic Stress Incontinence, Surgical Treatment (Green-top Guideline No. 35)
  67. Vasa Praevia: Diagnosis and Management (Green-top Guideline 27b)2018

  68. Venous Thromboembolism and Hormonal Contraception (Green-top Guideline No. 40) Venous Thromboembolism and Hormone Replacement Therapy (Green-top Guideline No. 19)
  69. Vulval Skin Disorders, Management (Green-top Guideline No. 58)
  70. RCOG Green-top guidelines in development: quarterly upd